血瘀模型大鼠中血塞通分散片与阿司匹林的药代动力学相互作用
本研究在血瘀模型大鼠中探究血塞通分散片(XST)与阿司匹林(ASA)联合给药后的药代动力学相互作用。采用UHPLC-MS/MS法同时测定大鼠血浆中人参皂苷Rg1、Rd、三七皂苷R1及水杨酸(SA)浓度。结果显示ASA与XST联用明显改变了R1和Rg1的吸收、分布与处置,提示二者存在明显的草药-药物药代动力学相互作用。
要点
- 血塞通分散片与阿司匹林联用可改变三七皂苷R1和人参皂苷Rg1的药代动力学。
- 该相互作用在血瘀模型大鼠中表现为吸收、分布和处置的改变。
- 临床联用血塞通分散片与阿司匹林时需关注潜在药代动力学相互作用。
核心结论
- 血塞通分散片与阿司匹林联合给药可在血瘀模型大鼠中引起明显的草药-药物药代动力学相互作用。
研究设计与样本
- 研究在血瘀模型大鼠中开展,采用UHPLC-MS/MS法同时测定血浆中人参皂苷Rg1、人参皂苷Rd、三七皂苷R1和水杨酸(SA)浓度。
主要发现
- 阿司匹林与血塞通分散片联用明显改变了三七皂苷R1和人参皂苷Rg1的吸收、分布和处置。
临床怎么用
- 临床联合使用血塞通分散片与阿司匹林时,应关注两者潜在的药代动力学相互作用,以确保用药安全有效。
局限性
- 研究为血瘀模型大鼠中的临床前药代动力学研究,结论外推至人体需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Xuesaitong dispersible tablet (XST) product has been clinically proven to be effective for treating cardio-cerebrovascular disease. Furthermore, herb-drug interactions between the XST product and drugs that are commonly co-administered, such as aspirin (ASA), must be explored to ensure safe clinical use. STUDY DESIGN AND METHODS: The current study aims to investigate whether the XST product interacts with ASA when they are administered concomitantly to ensure safety and efficacy. A ultra-high performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) method was developed for the simultaneous determination of ginsenoside Rg1 (Rg1), ginsenoside Rd (Rd), notoginsenoside R1 (R1) and salicylic acid (SA) in rat plasma to investigate the pharmacokinetic interaction of XST and ASA in blood stasis model rats. RESULTS AND CONCLUSION: The ASA and XST combination noticeably altered R1 and Rg1 absorption, distribution and disposition. This study indicates that co-administration of XST and ASA can cause an apparent herb-drug pharmacokinetic interaction in blood stasis model rats.
引用
- Dai G, Jiang Z, Bai Y, et al. Pharmacokinetic herb-drug interaction of Xuesaitong dispersible tablet and aspirin after oral administration in blood stasis model rats. Phytomedicine. 2017. PMID: 28257666. doi:10.1016/j.phymed.2017.01.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。